| Field | Row 1 |
|---|---|
| adsh | 0001437749-25-015868 |
| cik | 1818644 |
| name | AEYE, INC. |
| sic | 3714 |
| countryba | US |
| stprba | CA |
| cityba | PLEASANTON |
| zipba | 94588 |
| bas1 | 4670 WILLOW ROAD, SUITE 125 |
| bas2 | |
| baph | 925-400-4366 |
| countryma | US |
| stprma | CA |
| cityma | PLEASANTON |
| zipma | 94588 |
| mas1 | 4670 WILLOW ROAD, SUITE 125 |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 371827430 |
| former | CF FINANCE ACQUISITION CORP. III |
| changed | 20200717 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250512 |
| accepted | 2025-05-09 18:04:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | aeye20250331_10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001437749-25-015868 | 20250331 | Accounts Receivable Net Current | 6000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Additional Paid In Capital | 388213000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2501000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Assets | 27120000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Assets Current | 25171000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Assets Current | 26962000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -7397000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Common Stock Shares Outstanding | 13734160.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Convertible Debt Current | 3233000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Cost Of Revenue | 96000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Debt Issuance Costs Included In Accounts Payable And Accrued Liabilities | 45000.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20250331 | Earnings Per Share Basic | -0.4600 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Income Tax Expense Benefit | 2000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Development Contracts; | ||
| 0001437749-25-015868 | 20240331 | Increase Decrease In Inventories | -18000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Increase Decrease In Other Noncurrent Assets | -97000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Increase Decrease In Other Noncurrent Assets | -80000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Interest Expense And Other Nonoperating Expense | 2108000.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20241231 | Liabilities Current | 11307000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20250331 | Net Income Loss | -8016000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -14000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 1000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001437749-25-015868 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Prepaid Expense And Other Assets Current | 2706000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Retained Earnings Accumulated Deficit | -381111000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 20000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 5000.0000 | USD | 1 | us-gaap/2025 | Geographical= Europe; | ||
| 0001437749-25-015868 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2025 | Geographical= U S; | ||
| 0001437749-25-015868 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Product; | ||
| 0001437749-25-015868 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 64000.0000 | USD | 1 | us-gaap/2025 | Timing Of Transfer Of Good Or Service= Transferred Over Time; | ||
| 0001437749-25-015868 | 20231231 | Stockholders Equity | 10000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001437749-25-015868 | 20240331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20241231 | Stockholders Equity | 388213000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Shares New Issues | 129000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Shares New Issues | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Shares New Issues | 5887640.0000 | shares | 2 | us-gaap/2025 | Counterparty Name= Alliance Global Partners Agp; Subsidiary Sale Of Stock= At Market Issuance Sales Agreement The Atm; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Shares New Issues | 3480713.0000 | shares | 3 | us-gaap/2025 | Counterparty Name= New Circle Principal Investments L L C; Subsidiary Sale Of Stock= Share Purchase Agreement; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 74000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 333000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20240331 | Amortization Of Financing Costs | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Common Stock Shares Outstanding | 18690177.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities | 680000.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20240331 | Gain Loss On Termination Of Lease | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -10217000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Prototype Sales; | ||
| 0001437749-25-015868 | 20250331 | Increase Decrease In Inventories | -4000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 51000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 1000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 45000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Payments To Acquire Property Plant And Equipment | 87000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Payments To Acquire Property Plant And Equipment | 6000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Proceeds From Convertible Debt | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Research And Development Expense | 4532000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 20000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Product; | ||
| 0001437749-25-015868 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 64000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 64000.0000 | USD | 1 | us-gaap/2025 | Geographical= Europe; | ||
| 0001437749-25-015868 | 20231231 | Shares Outstanding | 6310090.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Shares Paid For Tax Withholding For Share Based Compensation | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20231231 | Stockholders Equity | 29023000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Stockholders Equity | -4000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001437749-25-015868 | 20240331 | Stockholders Equity | 369781000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20241231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Stockholders Equity | 6000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001437749-25-015868 | 20250331 | Stockholders Equity | 6000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Value New Issues | 165000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Value New Issues | 7816000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Accounts Payable Current | 3598000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Accounts Payable Current | 3850000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Accounts Receivable Net Current | 11000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Accrued Expenses And Other Current Liabilities | 3686000.0000 | USD | 0 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20250331 | Additional Paid In Capital | 398101000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3014000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Available For Sale Securities Debt Securities Current | 20659000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 10266000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Comprehensive Income Net Of Tax | -10233000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities | 2000.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20250331 | Gross Profit | -32000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Income Taxes Paid Net | 2000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Income Taxes Paid Net | 22000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Income Tax Expense Benefit | 2000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Increase Decrease In Accounts Receivable | -5000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -1343000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -98000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Liabilities | 11798000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Net Cash Provided By Used In Financing Activities | 11382000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Net Income Loss | -8016000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Operating Expenses | 6768000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Operating Lease Right Of Use Asset | 601000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Payments Of Financing Costs | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Property Plant And Equipment Net | 574000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2025 | Timing Of Transfer Of Good Or Service= Transferred At Point In Time; | ||
| 0001437749-25-015868 | 20240331 | Selling And Marketing Expense | 341000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Selling And Marketing Expense | 383000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20240331 | Shares Paid For Tax Withholding For Share Based Compensation | 34694.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Stockholders Equity | -4000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20241231 | Stockholders Equity | 15124000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Stockholders Equity | -373095000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | 0.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20240731 | Stock Issued During Period Value New Issues | 282000.0000 | USD | 0 | us-gaap/2025 | Counterparty Name= New Circle Principal Investments L L C; Subsidiary Sale Of Stock= Share Purchase Agreement; | ||
| 0001437749-25-015868 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 17448617.0000 | shares | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Accrued Expenses And Other Current Liabilities | 7709000.0000 | USD | 0 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 45000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3014000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 11685000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 5267000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001437749-25-015868 | 20240331 | Earnings Per Share Basic | -1.6100 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Gain Loss On Termination Of Lease | 1685000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Increase Decrease In Operating Lease Liability | -397000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Interest And Other Income | 195000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Inventory Net | 101000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Inventory Writedown Net Of Scrapped Inventory | 19000.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20250331 | Liabilities And Stockholders Equity | 28796000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Liabilities Current | 10769000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Net Cash Provided By Used In Financing Activities | 120000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Operating Expenses | 10488000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Operating Income Loss | -6800000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Operating Lease Liability Noncurrent | 420000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 364000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -14000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20240331 | Payments Of Stock Issuance Costs | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Proceeds From Issuance Of Common Stock | 165000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Proceeds From Sale And Maturity Of Available For Sale Securities | 6500000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Property Plant And Equipment Net | 605000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Retained Earnings Accumulated Deficit | -373095000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Stockholders Equity | 398101000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20240430 | Stock Issued During Period Shares New Issues | 330823.0000 | shares | 0 | us-gaap/2025 | Counterparty Name= An Investor; Subsidiary Sale Of Stock= Security Purchase Agreement; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 838656.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20241231 | Cash And Cash Equivalents At Carrying Value | 5823000.0000 | USD | 0 | us-gaap/2025 | Fair Value By Asset Class= Money Market Funds; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001437749-25-015868 | 20241231 | Common Stock Shares Authorized | 600000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Common Stock Shares Issued | 18690177.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20230331 | Convertible Debt Current | 3296000.0000 | USD | 0 | us-gaap/2025 | Debt Instrument= The2025 Note; | ||
| 0001437749-25-015868 | 20250331 | Convertible Debt Noncurrent | 146000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Cost Of Revenue | 263000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | 1362000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Gain Loss On Termination Of Lease | 5954000.0000 | USD | 4 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Gross Profit | -243000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Income Tax Expense Benefit | 2000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Development Contracts; | ||
| 0001437749-25-015868 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -772000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Inventory Writedown Net Of Scrapped Inventory | 24000.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20250331 | Net Cash Provided By Used In Investing Activities | -8578000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Net Cash Provided By Used In Operating Activities | -7885000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20250331 | Nonoperating Income Expense | -1214000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Operating Lease Liability Noncurrent | 479000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 1000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Provision For Doubtful Accounts | 14000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Technology Service; | ||
| 0001437749-25-015868 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 20000.0000 | USD | 1 | us-gaap/2025 | Timing Of Transfer Of Good Or Service= Transferred At Point In Time; | ||
| 0001437749-25-015868 | 20250331 | Share Based Compensation | 2501000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Shares Outstanding | 13734160.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20231231 | Stockholders Equity | 10000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20231231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20231231 | Stockholders Equity | -337635000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20240331 | Stockholders Equity | 21924000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Stockholders Equity | 16998000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Stockholders Equity | -381111000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Shares New Issues | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Value New Issues | 1000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Value New Issues | 8244000.0000 | USD | 2 | us-gaap/2025 | Counterparty Name= Alliance Global Partners Agp; Subsidiary Sale Of Stock= At Market Issuance Sales Agreement The Atm; | ||
| 0001437749-25-015868 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 252000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 5000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 45000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 333000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2501000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 95000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Cash And Cash Equivalents At Carrying Value | 10266000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001437749-25-015868 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Convertible Debt Current | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Debt Issuance Costs Included In Accounts Payable And Accrued Liabilities | 0.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20240331 | Depreciation Depletion And Amortization | 29000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Depreciation Depletion And Amortization | 37000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | General And Administrative Expense | 2895000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -8014000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Prototype Sales; | ||
| 0001437749-25-015868 | 20250331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -2408000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Increase Decrease In Other Noncurrent Liabilities | -358000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Increase Decrease In Other Noncurrent Liabilities | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Interest And Other Income | 214000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Inventory Net | 176000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Liabilities | 11996000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Noncash Common Stock Purchase Agreement Costs | 111000.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20240331 | Operating Income Loss | -10731000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Operating Lease Right Of Use Asset | 652000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -14000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | 1000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20241231 | Other Liabilities Noncurrent | 64000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Payments Of Financing Costs | 578000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Payments Of Stock Issuance Costs | 152000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 333000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Proceeds From Issuance Of Common Stock | 9495000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Research And Development Expense | 3490000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 64000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Technology Service; | ||
| 0001437749-25-015868 | 20240331 | Share Based Compensation | 3014000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20240331 | Stockholders Equity | -347854000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 98623.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Value New Issues | 165000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Value New Issues | 7815000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20250331 | Assets | 28796000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 95000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20250331 | Amortization Of Financing Costs | 1984000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Available For Sale Securities Debt Securities Current | 12012000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Common Stock Shares Authorized | 600000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Common Stock Shares Issued | 13734160.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Convertible Debt Noncurrent | 146000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | General And Administrative Expense | 5615000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Increase Decrease In Accounts Payable | 309000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Increase Decrease In Accounts Payable | 222000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Increase Decrease In Operating Lease Liability | -57000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Liabilities And Stockholders Equity | 27120000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Net Cash Provided By Used In Investing Activities | 368000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Net Income Loss | -10219000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20240331 | Noncash Common Stock Purchase Agreement Costs | 0.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20250331 | Other Assets Noncurrent | 659000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Prepaid Expense And Other Assets Current | 929000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Proceeds From Convertible Debt | 2950000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Proceeds From Sale And Maturity Of Available For Sale Securities | 5731000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Provision For Doubtful Accounts | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 15000.0000 | USD | 1 | us-gaap/2025 | Geographical= U S; | ||
| 0001437749-25-015868 | 20231231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20240331 | Shares Paid For Tax Withholding For Share Based Compensation | 0.0000 | shares | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20231231 | Stockholders Equity | 366647000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001437749-25-015868 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 6352835.0000 | shares | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 6000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Cash And Cash Equivalents At Carrying Value | 5267000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Cash And Cash Equivalents At Carrying Value | 4778000.0000 | USD | 0 | us-gaap/2025 | Fair Value By Asset Class= Money Market Funds; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001437749-25-015868 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 19082000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -4999000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Comprehensive Income Net Of Tax | -8015000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | USD | 1 | us-gaap/2025 | ||||
| 0001437749-25-015868 | 20250331 | Income Tax Expense Benefit | 2000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Increase Decrease In Accounts Receivable | -50000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Interest Expense And Other Nonoperating Expense | -317000.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20250331 | Net Cash Provided By Used In Operating Activities | -7803000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Net Income Loss | -10219000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20240331 | Nonoperating Income Expense | 514000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20241231 | Other Assets Noncurrent | 692000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Other Liabilities Noncurrent | 463000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20240331 | Payments To Acquire Available For Sale Securities Debt | 6045000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250331 | Payments To Acquire Available For Sale Securities Debt | 14303000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001437749-25-015868 | 20250131 | Proceeds From Convertible Debt | 3000000.0000 | USD | 0 | us-gaap/2025 | Debt Instrument= The2025 Note; | ||
| 0001437749-25-015868 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2025 | Timing Of Transfer Of Good Or Service= Transferred Over Time; | ||
| 0001437749-25-015868 | 20240331 | Shares Outstanding | 6503019.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Shares Outstanding | 18690177.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20250331 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20250331 | Shares Paid For Tax Withholding For Share Based Compensation | 396662.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001437749-25-015868 | 20241231 | Stockholders Equity | 5000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001437749-25-015868 | 20241231 | Stockholders Equity | 5000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20250331 | Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | 252000.0000 | USD | 1 | 0001437749-25-015868 | |||
| 0001437749-25-015868 | 20240731 | Stock Issued During Period Shares New Issues | 225563.0000 | shares | 0 | us-gaap/2025 | Counterparty Name= New Circle Principal Investments L L C; Subsidiary Sale Of Stock= Share Purchase Agreement; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Shares New Issues | 4514023.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001437749-25-015868 | 20240331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001437749-25-015868 | 20250331 | Stock Issued During Period Value New Issues | 6480000.0000 | USD | 3 | us-gaap/2025 | Counterparty Name= New Circle Principal Investments L L C; Subsidiary Sale Of Stock= Share Purchase Agreement; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Noncash Common Stock Purchase Agreement Costs | 0001437749-25-015868 | 1 | 0 | monetary | D | D | Common stock purchase agreement costs | Amount of noncash common stock purchase agreement costs. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Convertible Debt Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Convertible Debt, Current | The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. |
| Shares Paid For Tax Withholding For Share Based Compensation | us-gaap/2025 | 0 | 0 | shares | D | Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement. | |
| Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities | 0001437749-25-015868 | 1 | 0 | monetary | D | C | Change in fair value of convertible note and warrant liabilities | Represents the change in fair value of convertible notes and warrant liabilities. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Proceeds From Issuance Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Increase Decrease In Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest And Other Income | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). |
| Payments Of Financing Costs | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments of Financing Costs | The cash outflow for loan and debt issuance costs. |
| Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
| Depreciation Depletion And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Comprehensive Income Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2025 | 0 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. |
| Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Increase Decrease In Inventories | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Accounts Receivable Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Convertible Debt Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Convertible Debt, Noncurrent | Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock. |
| Cost Of Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Payments Of Stock Issuance Costs | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Payments To Acquire Available For Sale Securities Debt | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Debt Securities, Available-for-Sale | Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Selling And Marketing Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Payments To Acquire Property Plant And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Amortization Of Financing Costs | us-gaap/2025 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs | Amount of amortization expense attributable to debt issuance costs. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale | Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Stock Issued During Period Shares New Issues | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Inventory Writedown Net Of Scrapped Inventory | 0001437749-25-015868 | 1 | 0 | monetary | D | D | Inventory write-downs, net of scrapped inventory | Amount of write down of inventory net of scrapped inventory. |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Increase Decrease In Accounts Receivable | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Adjustments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation | Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement. |
| Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | us-gaap/2025 | 0 | 0 | monetary | D | D | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction. |
| Proceeds From Convertible Debt | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Convertible Debt | The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. |
| Accrued Expenses And Other Current Liabilities | 0001437749-25-015868 | 1 | 0 | monetary | I | C | Accrued expenses and other current liabilities | Represents the amount of accrued expenses and other current liabilities. |
| Debt Issuance Costs Included In Accounts Payable And Accrued Liabilities | 0001437749-25-015868 | 1 | 0 | monetary | D | D | Debt issuance costs included in accounts payable and accrued liabilities | Amount of debt issuance costs included in accounts payable and accrued liabilities. |
| Interest Expense And Other Nonoperating Expense | 0001437749-25-015868 | 1 | 0 | monetary | D | D | lidr_InterestExpenseAndOtherNonoperatingExpense | Represents the amount of interest expense and other nonoperating expense classified as other. |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Inventory Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Available For Sale Securities Debt Securities Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Debt Securities, Available-for-Sale, Current | Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current. |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | 0001437749-25-015868 | 1 | 0 | monetary | D | D | Stock issuance costs included in accounts payable and accrued liabilities | The amount of stock issuance costs that were incurred during a noncash or partial noncash transaction. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Increase Decrease In Other Noncurrent Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Noncurrent Liabilities | Amount of increase (decrease) in noncurrent operating liabilities classified as other. |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Provision For Doubtful Accounts | us-gaap/2025 | 0 | 0 | monetary | D | D | Accounts Receivable, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss on accounts receivable. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Income Taxes Paid Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Stock Issued During Period Value New Issues | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2025 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Gain Loss On Termination Of Lease | us-gaap/2025 | 0 | 0 | monetary | D | C | Gain (Loss) on Termination of Lease | Amount of gain (loss) on termination of lease before expiration of lease term. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001437749-25-015868 | 2 | 4 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001437749-25-015868 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preferred stock, shares issued (in shares) | 0 |
| 0001437749-25-015868 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preferred Stock, Shares Outstanding | 0 |
| 0001437749-25-015868 | 3 | 7 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in dollars per share) | 0 |
| 0001437749-25-015868 | 3 | 8 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized (in shares) | 0 |
| 0001437749-25-015868 | 3 | 9 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued (in shares) | 0 |
| 0001437749-25-015868 | 3 | 10 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding (in shares) | 0 |
| 0001437749-25-015868 | 4 | 7 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | Revenue | 0 |
| 0001437749-25-015868 | 4 | 8 | IS | 0 | H | Cost Of Revenue | us-gaap/2025 | Cost of revenue | 0 |
| 0001437749-25-015868 | 4 | 9 | IS | 0 | H | Gross Profit | us-gaap/2025 | Gross loss | 0 |
| 0001437749-25-015868 | 4 | 11 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development | 0 |
| 0001437749-25-015868 | 4 | 12 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2025 | Sales and marketing | 0 |
| 0001437749-25-015868 | 4 | 13 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
| 0001437749-25-015868 | 4 | 14 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
| 0001437749-25-015868 | 4 | 15 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | LOSS FROM OPERATIONS | 0 |
| 0001437749-25-015868 | 4 | 17 | IS | 0 | H | Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities | 0001437749-25-015868 | Change in fair value of convertible note and warrant liabilities | 0 |
| 0001437749-25-015868 | 4 | 18 | IS | 0 | H | Interest And Other Income | us-gaap/2025 | Interest income and other | 0 |
| 0001437749-25-015868 | 4 | 19 | IS | 0 | H | Interest Expense And Other Nonoperating Expense | 0001437749-25-015868 | Interest expense and other | 1 |
| 0001437749-25-015868 | 4 | 20 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Total other income (expense), net | 0 |
| 0001437749-25-015868 | 4 | 21 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Loss before income tax expense | 0 |
| 0001437749-25-015868 | 4 | 22 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Provision for income tax expense | 0 |
| 0001437749-25-015868 | 4 | 23 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001437749-25-015868 | 4 | 24 | IS | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2025 | Change in net unrealized gain (loss) on available-for-sale securities, net of tax | 0 |
| 0001437749-25-015868 | 4 | 25 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2025 | Comprehensive loss | 0 |
| 0001437749-25-015868 | 4 | 27 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Net loss per share (basic and diluted) (in dollars per share) | 0 |
| 0001437749-25-015868 | 4 | 28 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average shares outstanding (basic and diluted) (in shares) | 0 |
| 0001437749-25-015868 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | BALANCE (in shares) | 0 |
| 0001437749-25-015868 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001437749-25-015868 | 5 | 12 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | Stock-based compensation | 0 |
| 0001437749-25-015868 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2025 | Issuance of common stock upon vesting of restricted stock units (in shares) | 0 |
| 0001437749-25-015868 | 5 | 14 | EQ | 0 | H | Shares Paid For Tax Withholding For Share Based Compensation | us-gaap/2025 | Taxes related to net share settlement of equity awards (in shares) | 1 |
| 0001437749-25-015868 | 5 | 15 | EQ | 0 | H | Adjustments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | Taxes related to net share settlement of equity awards | 1 |
| 0001437749-25-015868 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2025 | Issuance of common stock under the Common Stock Purchase Agreements (in shares) | 0 |
| 0001437749-25-015868 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2025 | Issuance of common stock under the Common Stock Purchase Agreements | 0 |
| 0001437749-25-015868 | 5 | 18 | EQ | 0 | H | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2025 | Transaction costs related to the Common Stock Purchase Agreements | 1 |
| 0001437749-25-015868 | 5 | 19 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2025 | Other comprehensive income, net of tax | 0 |
| 0001437749-25-015868 | 5 | 20 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001437749-25-015868 | 5 | 21 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | BALANCE (in shares) | 0 |
| 0001437749-25-015868 | 5 | 22 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001437749-25-015868 | 6 | 4 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001437749-25-015868 | 6 | 6 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2025 | Depreciation and amortization | 0 |
| 0001437749-25-015868 | 6 | 7 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | Noncash lease expense relating to operating lease right-of-use assets | 0 |
| 0001437749-25-015868 | 6 | 8 | CF | 0 | H | Gain Loss On Termination Of Lease | us-gaap/2025 | Gain on termination of operating lease, net | 1 |
| 0001437749-25-015868 | 6 | 9 | CF | 0 | H | Noncash Common Stock Purchase Agreement Costs | 0001437749-25-015868 | Common stock purchase agreement costs | 0 |
| 0001437749-25-015868 | 6 | 10 | CF | 0 | H | Amortization Of Financing Costs | us-gaap/2025 | Debt issuance costs | 0 |
| 0001437749-25-015868 | 6 | 11 | CF | 0 | H | Inventory Writedown Net Of Scrapped Inventory | 0001437749-25-015868 | Inventory write-downs, net of scrapped inventory | 0 |
| 0001437749-25-015868 | 6 | 12 | CF | 0 | H | Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities | 0001437749-25-015868 | Change in fair value of convertible note and warrant liabilities | 1 |
| 0001437749-25-015868 | 6 | 13 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation | 0 |
| 0001437749-25-015868 | 6 | 14 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2025 | Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest | 1 |
| 0001437749-25-015868 | 6 | 15 | CF | 0 | H | Provision For Doubtful Accounts | us-gaap/2025 | Expected credit losses, net of write-off | 0 |
| 0001437749-25-015868 | 6 | 17 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2025 | Accounts receivable, net | 1 |
| 0001437749-25-015868 | 6 | 18 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2025 | Inventories, current and noncurrent, net | 1 |
| 0001437749-25-015868 | 6 | 19 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid and other current assets | 1 |
| 0001437749-25-015868 | 6 | 20 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2025 | Other noncurrent assets | 1 |
| 0001437749-25-015868 | 6 | 21 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001437749-25-015868 | 6 | 22 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2025 | Accrued expenses and other current liabilities | 0 |
| 0001437749-25-015868 | 6 | 23 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2025 | Operating lease liabilities | 0 |
| 0001437749-25-015868 | 6 | 24 | CF | 0 | H | Increase Decrease In Other Noncurrent Liabilities | us-gaap/2025 | Other noncurrent liabilities | 0 |
| 0001437749-25-015868 | 6 | 25 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001437749-25-015868 | 6 | 27 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2025 | Purchases of property and equipment | 1 |
| 0001437749-25-015868 | 6 | 28 | CF | 0 | H | Payments To Acquire Available For Sale Securities Debt | us-gaap/2025 | Purchases of marketable securities | 1 |
| 0001437749-25-015868 | 6 | 29 | CF | 0 | H | Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2025 | Proceeds from redemptions and maturities of marketable securities | 0 |
| 0001437749-25-015868 | 6 | 30 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash (used in) provided by investing activities | 0 |
| 0001437749-25-015868 | 6 | 32 | CF | 0 | H | Proceeds From Convertible Debt | us-gaap/2025 | Proceeds from issuance of convertible note | 0 |
| 0001437749-25-015868 | 6 | 33 | CF | 0 | H | Payments Of Financing Costs | us-gaap/2025 | Transaction costs related to issuance of convertible note | 1 |
| 0001437749-25-015868 | 6 | 34 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | Taxes paid related to the net share settlement of equity awards | 1 |
| 0001437749-25-015868 | 6 | 35 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2025 | Proceeds from issuance of common stock under Common Stock Purchase Agreements | 0 |
| 0001437749-25-015868 | 6 | 36 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2025 | Stock issuance costs related to Common Stock Purchase Agreements | 1 |
| 0001437749-25-015868 | 6 | 37 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by financing activities | 0 |
| 0001437749-25-015868 | 6 | 38 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | 0 |
| 0001437749-25-015868 | 6 | 39 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | CASH, CASH EQUIVALENTS AND RESTRICTED CASHBeginning of period | 0 |
| 0001437749-25-015868 | 6 | 40 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | CASH, CASH EQUIVALENTS AND RESTRICTED CASHEnd of period | 0 |
| 0001437749-25-015868 | 6 | 42 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2025 | Cash paid for income taxes, net of refund | 0 |
| 0001437749-25-015868 | 6 | 44 | CF | 0 | H | Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | us-gaap/2025 | Noncash debt issuance costs | 0 |
| 0001437749-25-015868 | 6 | 45 | CF | 0 | H | Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | 0001437749-25-015868 | Stock issuance costs included in accounts payable and accrued liabilities | 0 |
| 0001437749-25-015868 | 6 | 46 | CF | 0 | H | Debt Issuance Costs Included In Accounts Payable And Accrued Liabilities | 0001437749-25-015868 | Debt issuance costs included in accounts payable and accrued liabilities | 0 |
| 0001437749-25-015868 | 2 | 5 | BS | 0 | H | Available For Sale Securities Debt Securities Current | us-gaap/2025 | Marketable securities | 0 |
| 0001437749-25-015868 | 2 | 6 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2025 | Accounts receivable, net | 0 |
| 0001437749-25-015868 | 2 | 7 | BS | 0 | H | Inventory Net | us-gaap/2025 | Inventories, net | 0 |
| 0001437749-25-015868 | 2 | 8 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid and other current assets | 0 |
| 0001437749-25-015868 | 2 | 9 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001437749-25-015868 | 2 | 10 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Right-of-use assets | 0 |
| 0001437749-25-015868 | 2 | 11 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Property and equipment, net | 0 |
| 0001437749-25-015868 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Other noncurrent assets | 0 |
| 0001437749-25-015868 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001437749-25-015868 | 2 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001437749-25-015868 | 2 | 16 | BS | 0 | H | Accrued Expenses And Other Current Liabilities | 0001437749-25-015868 | Accrued expenses and other current liabilities | 0 |
| 0001437749-25-015868 | 2 | 17 | BS | 0 | H | Convertible Debt Current | us-gaap/2025 | Convertible note, current | 0 |
| 0001437749-25-015868 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001437749-25-015868 | 2 | 19 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Operating lease liabilities, noncurrent | 0 |
| 0001437749-25-015868 | 2 | 20 | BS | 0 | H | Convertible Debt Noncurrent | us-gaap/2025 | Convertible note, noncurrent | 0 |
| 0001437749-25-015868 | 2 | 21 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2025 | Other noncurrent liabilities | 0 |
| 0001437749-25-015868 | 2 | 22 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001437749-25-015868 | 2 | 23 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | COMMITMENTS AND CONTINGENCIES (Note 17) | 0 |
| 0001437749-25-015868 | 2 | 25 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Preferred stock$0.0001 par value: 1,000,000 shares authorized; no shares issued and outstanding | 0 |
| 0001437749-25-015868 | 2 | 26 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock$0.0001 par value: 600,000,000 shares authorized; 18,690,177 and 13,734,160 shares issued and outstanding at March 31, 2025 and December 31, 2024 | 0 |
| 0001437749-25-015868 | 2 | 27 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001437749-25-015868 | 2 | 28 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | Accumulated other comprehensive income | 0 |
| 0001437749-25-015868 | 2 | 29 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001437749-25-015868 | 2 | 30 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders equity | 0 |
| 0001437749-25-015868 | 2 | 31 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and stockholders equity | 0 |
| 0001437749-25-015868 | 3 | 3 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preferred stock, par value (in dollars per share) | 0 |
| 0001437749-25-015868 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preferred stock, shares authorized (in shares) | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |